Inbound Medical Support - UFH International Medical Service Center

Chair of Urology and Chair of Surgery at UFH Beijing. He holds a doctorate and post-doctoral clinical research fellowship from King’s College London. Dr. Zhu is Vice-Chairman of the China Anti-Cancer Association Genitourinary Oncology Committee (CACA-GU). A pioneer in robotic urological surgery in China, he specializes in robotic-assisted surgery for prostate, kidney, and bladder cancers, as well as advanced retroperitoneal lymph node dissection and vascular-adjacent tumor surgery.

Dr. Hua Surong previously affiliated with the General Surgery Department of PUMCH, he specializes in aesthetic, scarless thyroid surgery using trans-axillary and trans-areolar approaches with laparoscopic and robotic techniques, as well as minimally invasive and robotic surgery for pancreatic and gastric tumors. In 2024, he was recognized as a “Future Star” in healthcare by the Capital Health Commission.

A pioneer in digestive endoscopy in China, he pioneered EUS-guided iodine-125 particle implantation for esophageal and duodenal papillary cancer and was the first in China to conduct NOTES experimental and clinical research. He specializes in endoscopic resection of early-stage GI cancer (ESD), minimally invasive treatment of pancreaticobiliary diseases (ERCP+EUS), and dual-scope treatment of complex GI tumors.

With over 20 years of clinical oncology experience, she specializes in the diagnosis and treatment of lung cancer, thoracic tumors, and solid tumors. She completed advanced training at the National Cancer Center of China and served as a visiting scholar at the University of Maryland, USA. Dr. Gu has published over ten academic articles in leading journals including the Chinese Journal of Lung Cancer.

Deputy General Manager of UFH Shanghai and Chief Physician of the Gastroenterology Center. As a leading expert in ERCP techniques, he pioneered a one-stop diagnostic and therapeutic platform for digestive endoscopy. He specializes in endoscopic management of complex pancreaticobiliary diseases including pancreatic cancer, cholangiocarcinoma, biliary and pancreatic stones, obstructive jaundice, and pediatric ERCP, with expertise in gastroscopy, colonoscopy, EUS, and pancreaticobiliary endoscope.

With over 30 years of clinical experience in Urology, Dr. Liu Dongming specializes in laparoscopic and Da Vinci robot-assisted minimally invasive surgery, leading his team to complete over 20,000 laparoscopic procedures and more than 5,000 nephron-sparing surgeries for renal tumors. A pioneer in China, he performed the nation’s first zero-ischemia laparoscopic nephron-sparing surgery using 3D imaging technology. He is expert in complex renal cell carcinoma, vena cava tumor thrombus, large adrenal tumors, and radical prostatectomy.

Director of the National Center for Respiratory Medicine and Dean of the Guangzhou Institute of Respiratory Health, and is a recipient of the State Council Special Allowance. A pioneer in thoracoscopic lung cancer resection in China and a global leader in tubeless spontaneous breathing airway surgery and needle thoracoscopy, he specializes in minimally invasive diagnosis and treatment of lung cancer, complex thoracic surgery, and heart-lung transplantation, with innovative contributions to ex vivo lung perfusion techniques.

Manages solid tumors (lung, breast, GI, liver) with expertise in chemo, targeted/immuno/endocrine therapy, and ADCs. Skilled in side effect management, treatment monitoring, and managing oncologic complications, including malignant effusions, cancer pain, and nutritional support.

Dr. Jia Lin Ph.D. in Oncology, Hebei Medical University; Postdoctoral Fellow in Tumor Immunology, Harvard Medical School / Massachusetts General Hospital. With over 20 years of experience in medical oncology, Dr. Lin has served at Hebei Cancer Hospital, Hebei University Affiliated Hospital, and a tertiary oncology hospital in Guangzhou. She is an active member of the Chinese Anti-Cancer Association (including its committees on Tumor Microenvironment, Clinical Research on Tumor Drugs, and Tumor Targeted Therapy), as well as ASCO and AACR.

Dr. Li Shunrong has 24 years of clinical experience and serves as Administrative Director of the Department of Oncoplastic Surgery at Sun Yat-sen Memorial Hospital Shenshan Center. Trained under Professor Fengxi Su in China and Professors Liza Wu and Roger K. Khouri in the U.S., he specializes in breast reconstruction, scarless tumor resection, and aesthetic breast surgery. He is Chairman of the Breast Plastic Surgery Branch of Guangdong Medical Industry Association and has published over 10 SCI papers.

Dr. Ma Dong has over 35 years of clinical experience and serves as Director of the Department of Medical Oncology at Guangdong Provincial People's Hospital. He holds memberships in multiple CSCO committees and serves as Vice Chairman of Guangzhou Anti-Cancer Association and Chairman of its Colorectal Cancer Committee. He specializes in standardized diagnosis and multidisciplinary treatment of malignant tumors, particularly gastrointestinal cancers (gastric, colorectal, pancreatic) and geriatric oncology.